Mitochondrial proteins in neuronal degeneration.

In this review, we highlight recent findings about the role of some mitochondrial proteins in neurological diseases. Studies in mice gene-deleted for Omi/HtrA2 and AIF showed the involvement of these mitochondrial proteins in selective cell degeneration in the spinal cord and brain. In humans, mutations in the mitochondrial protein, Paraplegin, cause an autosomal form of hereditary spastic paraplegia with an enhanced sensitivity to oxidative stress. Reactive oxygen species and decreased respiratory chain activity in mitochondria also contribute to common neurological diseases. The mitochondrial uncoupling protein, Ucp-2, was found to be neuroprotective in experimental stroke and brain trauma. Recent proteomic and profiling studies have revealed the existence of additional mitochondrial proteins with unknown functions. The elucidation of the physiological functions of mitochondrial proteins may lead to new insights into the role of these organelles in cell degeneration and to identification of novel drug targets for the prevention and treatment of different diseases.

[1]  J. Fink.  Advances in the hereditary spastic paraplegias , 2003, Experimental Neurology.

[2]  S. Cory,et al.  The Bcl-2 protein family: arbiters of cell survival. , 1998, Science.

[3]  D. Lindholm,et al.  Transgenic mice overexpressing XIAP in neurons show better outcome after transient cerebral ischemia , 2003, Molecular and Cellular Neuroscience.

[4]  G. Tomasevic,et al.  Uncoupling protein-2 prevents neuronal death and diminishes brain dysfunction after stroke and brain trauma , 2003, Nature Medicine.

[5]  L. Cantley,et al.  Binding Specificity and Regulation of the Serine Protease and PDZ Domains of HtrA2/Omi* , 2003, Journal of Biological Chemistry.

[6]  S. R. Datta,et al.  BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis , 2003, Nature.

[7]  Dean P. Jones,et al.  The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore , 2004, Nature.

[8]  T. Mak,et al.  Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death , 2001, Nature.

[9]  J. Melillo,et al.  Multi-gas assessment of the Kyoto Protocol , 1999, Nature.

[10]  Changlian Zhu,et al.  X-linked inhibitor of apoptosis (XIAP) protein protects against caspase activation and tissue loss after neonatal hypoxia–ischemia , 2004, Neurobiology of Disease.

[11]  S. Korsmeyer,et al.  Cell Death Critical Control Points , 2004, Cell.

[12]  F. Cecconi,et al.  Mitochondrial release of AIF and EndoG requires caspase activation downstream of Bax/Bak‐mediated permeabilization , 2003, The EMBO journal.

[13]  Changlian Zhu,et al.  Involvement of apoptosis‐inducing factor in neuronal death after hypoxia‐ischemia in the neonatal rat brain , 2003, Journal of neurochemistry.

[14]  M. Crompton,et al.  Increased Susceptibility of Striatal Mitochondria to Calcium-Induced Permeability Transition , 2003, The Journal of Neuroscience.

[15]  A. Ballabio,et al.  Loss of m-AAA protease in mitochondria causes complex I deficiency and increased sensitivity to oxidative stress in hereditary spastic paraplegia , 2003, The Journal of cell biology.

[16]  R. Clark,et al.  Translocation of Apoptosis-Inducing Factor in Vulnerable Neurons after Transient Cerebral Ischemia and in Neuronal Cultures after Oxygen-Glucose Deprivation , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[17]  Emad S. Alnemri,et al.  Structural insights into the pro-apoptotic function of mitochondrial serine protease HtrA2/Omi , 2002, Nature Structural Biology.

[18]  Xiaodong Wang,et al.  Exogenous Smac Induces Competence and Permits Caspase Activation in Sympathetic Neurons , 2002, The Journal of Neuroscience.

[19]  S. Srinivasula,et al.  Loss of Omi mitochondrial protease activity causes the neuromuscular disorder of mnd2 mutant mice , 2003, Nature.

[20]  Yuri Lazebnik,et al.  Identification of Omi/HtrA2 as a Mitochondrial Apoptotic Serine Protease That Disrupts Inhibitor of Apoptosis Protein-Caspase Interaction* , 2002, The Journal of Biological Chemistry.

[21]  Colin L. Masters,et al.  Neurodegenerative diseases and oxidative stress , 2004, Nature Reviews Drug Discovery.

[22]  C. Thompson,et al.  Critical function of endogenous XIAP in regulating caspase activation during sympathetic neuronal apoptosis , 2003, The Journal of cell biology.

[23]  Wayne N. Frankel,et al.  The harlequin mouse mutation downregulates apoptosis-inducing factor , 2002, Nature.

[24]  M. Meisler,et al.  Progressive Loss of Striatal Neurons Causes Motor Dysfunction in MND2 Mutant Mice and Is Not Prevented by Bcl-2 , 2002, Experimental Neurology.

[25]  S. Srinivasula,et al.  Cytochrome c and dATP-Dependent Formation of Apaf-1/Caspase-9 Complex Initiates an Apoptotic Protease Cascade , 1997, Cell.

[26]  D. Vaux,et al.  Mammalian mitochondrial IAP binding proteins. , 2003, Biochemical and biophysical research communications.

[27]  N. Cheong,et al.  Inhibitor of Apoptosis Proteins Are Substrates for the Mitochondrial Serine Protease Omi/HtrA2* , 2003, Journal of Biological Chemistry.

[28]  Masashi Narita,et al.  Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC , 1999, Nature.

[29]  S. Korsmeyer,et al.  VDAC2 Inhibits BAK Activation and Mitochondrial Apoptosis , 2003, Science.

[30]  Marjan S. Bolouri,et al.  Integrated Analysis of Protein Composition, Tissue Diversity, and Gene Regulation in Mouse Mitochondria , 2003, Cell.

[31]  Jean-Claude Martinou,et al.  Breaking the mitochondrial barrier , 2001, Nature Reviews Molecular Cell Biology.

[32]  Jinyu Ren,et al.  Omi/HtrA2 catalytic cleavage of inhibitor of apoptosis (IAP) irreversibly inactivates IAPs and facilitates caspase activity in apoptosis. , 2003, Genes & development.

[33]  S. Lipton,et al.  Dueling Activities of AIF in Cell Death versus Survival DNA Binding and Redox Activity , 2002, Cell.

[34]  S. R. Datta,et al.  Cellular survival: a play in three Akts. , 1999, Genes & development.

[35]  M. Maurizi.  Love it or cleave it: Tough choices in protein quality control , 2002, Nature Structural Biology.

[36]  R. Moritz,et al.  HtrA2 Promotes Cell Death through Its Serine Protease Activity and Its Ability to Antagonize Inhibitor of Apoptosis Proteins* , 2002, The Journal of Biological Chemistry.

[37]  Simon C Watkins,et al.  Intranuclear localization of apoptosis‐inducing factor (AIF) and large scale dna fragmentation after traumatic brain injury in rats and in neuronal cultures exposed to peroxynitrite , 2002, Journal of neurochemistry.

[38]  T. Hashikawa,et al.  Mitochondrial protease Omi/HtrA2 enhances caspase activation through multiple pathways , 2004, Cell Death and Differentiation.

[39]  S. Srinivasula,et al.  Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization. , 1998, Molecular cell.

[40]  R. Korneluk,et al.  XIAP, the guardian angel , 2001, Nature Reviews Molecular Cell Biology.

[41]  Jean-Claude Martinou,et al.  Proteomic Analysis of the Mouse Liver Mitochondrial Inner Membrane* , 2003, Journal of Biological Chemistry.

[42]  Bradford W. Gibson,et al.  Characterization of the human heart mitochondrial proteome , 2003, Nature Biotechnology.

[43]  X. Roucou,et al.  Conformational change of Bax: a question of life or death , 2001, Cell Death and Differentiation.

[44]  T. Dawson,et al.  Molecular Pathways of Neurodegeneration in Parkinson's Disease , 2003, Science.

[45]  N. Thornberry,et al.  Life and Death Decisions , 2003, Science.

[46]  A. Strasser,et al.  BH3-Only Proteins—Essential Initiators of Apoptotic Cell Death , 2000, Cell.